The Global Relapsed Or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Market Is Driven By Growing Approval Of Novel Therapies
by Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin’s lymphoma (NHL) with heterogeneous histopathological features and clinical behavior. It is the most common …